Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-May-24 8:07 PM View:  | Nivalis Therapeutics, Inc. (ALPN) | 20-May-24 | Disposition | 57,961 | -- | -- | (100%) 57.96K to 0 | |
| 09-May-24 9:13 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 07-May-24 | Option Exercise | 26,761 | $6.04 | $161,629.00 | 86% 31.2K to 57.96K | |
| 29-Jan-24 7:04 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 26-Jan-24 | Option Exercise | 117,764 | $8.30 | $977,844.00 | 100% 0 to 117.76K | |
| 29-Jan-24 7:04 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 26-Jan-24 | Planned Option Sale | 117,764 | $23.32 | $2,745,830.00 | (100%) 117.76K to 0 | |
| 29-Jan-24 7:04 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 25-Jan-24 | Option Exercise | 236 | $6.51 | $1,536.36 | 100% 0 to 0.24K | |
| 29-Jan-24 7:04 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 25-Jan-24 | Planned Option Sale | 236 | $22.00 | $5,192.00 | (100%) 0.24K to 0 | |
| 05-Jan-24 6:07 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 04-Jan-24 | Grant | 31,200 | -- | -- | 100% 0 to 31.2K | |
| 21-Dec-23 7:35 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 19-Dec-23 | Option Exercise | 15,213 | $5.02 | $76,369.30 | 100% 0 to 15.21K | |
| 21-Dec-23 7:35 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 19-Dec-23 | Planned Option Sale | 15,213 | $19.21 | $292,222.00 | (100%) 15.21K to 0 | |
| 18-Dec-23 9:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 18-Dec-23 | Option Exercise | 1,800 | $5.02 | $9,036.00 | 100% 0 to 1.8K | |
| 18-Dec-23 9:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 18-Dec-23 | Planned Option Sale | 1,800 | $19.00 | $34,203.10 | (100%) 1.8K to 0 | |
| 18-Dec-23 9:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 15-Dec-23 | Option Exercise | 45,387 | $5.02 | $227,843.00 | 100% 0 to 45.39K | |
| 18-Dec-23 9:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 15-Dec-23 | Planned Option Sale | 45,387 | $19.09 | $866,383.00 | (100%) 45.39K to 0 | |
| 18-Dec-23 9:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 14-Dec-23 | Option Exercise | 11,600 | $5.02 | $58,232.00 | 100% 0 to 11.6K | |
| 18-Dec-23 9:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 14-Dec-23 | Planned Option Sale | 11,600 | $19.00 | $220,406.00 | (100%) 11.6K to 0 | |
| 06-Dec-23 7:31 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 06-Dec-23 | Option Exercise | 6,446 | $3.23 | $20,820.60 | 100% 0 to 6.45K | |
| 06-Dec-23 7:31 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 06-Dec-23 | Planned Option Sale | 6,446 | $16.08 | $103,650.00 | (100%) 6.45K to 0 | |
| 06-Dec-23 7:31 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 05-Dec-23 | Option Exercise | 418 | $3.23 | $1,350.14 | 100% 0 to 0.42K | |
| 06-Dec-23 7:31 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 05-Dec-23 | Planned Option Sale | 418 | $16.01 | $6,693.81 | (100%) 0.42K to 0 | |
| 06-Dec-23 7:31 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 04-Dec-23 | Option Exercise | 63,947 | $3.23 | $206,549.00 | 100% 0 to 63.95K | |
| 06-Dec-23 7:31 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 04-Dec-23 | Planned Option Sale | 63,947 | $16.06 | $1,026,890.00 | (100%) 63.95K to 0 | |
| 01-Dec-23 5:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 30-Nov-23 | Option Exercise | 700 | $3.23 | $2,261.00 | 100% 0 to 0.7K | |
| 01-Dec-23 5:00 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 30-Nov-23 | Planned Option Sale | 700 | $16.00 | $11,200.00 | (100%) 0.7K to 0 | |
| 08-Nov-23 5:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 06-Nov-23 | Option Exercise | 10,989 | $3.23 | $35,494.50 | 157% 7.01K to 18.0K | |
| 08-Nov-23 5:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 06-Nov-23 | Planned Option Sale | 10,989 | $16.03 | $176,133.00 | (61%) 18.0K to 7.01K | |
| 08-Nov-23 5:20 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 06-Nov-23 | Sale (Planned) | 7,014 | $16.03 | $112,421.00 | (100%) 7.01K to 0 | |
| 04-Jan-22 5:40 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 31-Dec-21 | Market Sale | 17,013 | $13.92 | $236,756.00 | (71%) 24.03K to 7.01K | (< 1%) |
| 04-Jan-21 8:31 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 31-Dec-20 | Payment of Exercise | 2,258 | $12.60 | $28,450.80 | (9%) 26.29K to 24.03K | < 1% |
| 01-Jul-20 7:38 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 30-Jun-20 | Payment of Exercise | 2,258 | $9.71 | $21,925.20 | (8%) 28.54K to 26.29K | (64%) |
| 27-Jan-20 6:02 PM View: | Nivalis Therapeutics, Inc. (ALPN) | 23-Jan-20 | Grant | 18,543 | -- | -- | 185% 10.0K to 28.54K | |
| 03-Jun-19 8:00 AM View: | Nivalis Therapeutics, Inc. (ALPN) | 30-May-19 | Market Purchase | 10,000 | $4.95 | $49,500.00 | 100% 0 to 10.0K | 223% |